{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:40:58Z","timestamp":1778172058982,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00280-018-3662-0","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T05:24:21Z","timestamp":1534137861000},"page":"777-785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity"],"prefix":"10.1007","volume":"82","author":[{"given":"Soo Jie","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Yoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rae-Young","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Chan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sae-Won","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2317-4201","authenticated-orcid":false,"given":"Hye-Ryun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"key":"3662_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364\u2013378","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"3662_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7(8):573","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"3662_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/jjco\/hyv081","volume":"45","author":"S Miyamoto","year":"2015","unstructured":"Miyamoto S, Okada R, Ando K (2015) Platinum hypersensitivity and desensitization. Jpn J Clin Oncol 45(9):795\u2013804","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"3662_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11882-014-0451-7","volume":"14","author":"J Caiado","year":"2014","unstructured":"Caiado J, Picard M (2014) Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell\/basophil mediators. Curr Allergy Asthma Rep 14(8):1\u201312","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"3662_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1048-891x.2005.14401.x","volume":"15","author":"S Sliesoraitis","year":"2005","unstructured":"Sliesoraitis S, Chikhale P (2005) Carboplatin hypersensitivity. Int J Gynecol Cancer 15(1):13\u201318","journal-title":"Int J Gynecol Cancer"},{"key":"3662_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/TCRM.S3583","volume":"5","author":"P Comella","year":"2009","unstructured":"Comella P, Casaretti R, Sandomenico C, Avallone A, Franco L (2009) Role of oxaliplatin in the treatment of colorectal cancer. Therap Clin Risk Manag 5:229","journal-title":"Therap Clin Risk Manag"},{"issue":"1","key":"3662_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1634\/theoncologist.5-1-26","volume":"5","author":"M Markman","year":"2000","unstructured":"Markman M, Bookman MA (2000) Second-line treatment of ovarian cancer. The Oncologist 5(1):26\u201335","journal-title":"The Oncologist"},{"key":"3662_CR8","unstructured":"Network NCC (2017) NCCN clinical practice guidelines in oncology-ovarian cancer including fallopian tube cancer and primary peritoneal cancer (Version 2.2017)"},{"issue":"3","key":"3662_CR9","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","volume":"122","author":"MC Castells","year":"2008","unstructured":"Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, Laidlaw TM, Legere HJ, Nallamshetty SN, Palis RI (2008) Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 122(3):574\u2013580","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"3662_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ygyno.2014.07.104","volume":"135","author":"Q Li","year":"2014","unstructured":"Li Q, Cohn D, Waller A, Backes F, Copeland L, Fowler J, Salani R, O\u2019Malley D (2014) Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin\/cisplatin. Gynecol Oncol 135(1):90\u201394","journal-title":"Gynecol Oncol"},{"issue":"2","key":"3662_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","volume":"114","author":"SG Brown","year":"2004","unstructured":"Brown SG (2004) Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 114(2):371\u2013376","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"3662_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ygyno.2005.06.028","volume":"99","author":"C-W Lee","year":"2005","unstructured":"Lee C-W, Matulonis UA, Castells MC (2005) Rapid inpatient\/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses. Gynecol Oncol 99(2):393\u2013399","journal-title":"Gynecol Oncol"},{"issue":"6","key":"3662_CR13","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.jaci.2009.02.042","volume":"123","author":"PE Hesterberg","year":"2009","unstructured":"Hesterberg PE, Banerji A, Oren E, Penson RT, Krasner CN, Seiden MV, Wong JT (2009) Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management. J Allergy Clin Immunol 123(6):1262\u20131267. e1261","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"3662_CR14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/all.12105","volume":"68","author":"R Madrigal-Burgaleta","year":"2013","unstructured":"Madrigal-Burgaleta R, Berges-Gimeno M, Angel-Pereira D, Ferreiro-Monteagudo R, Guillen-Ponce C, Pueyo C, Gomez de Salazar E, Alvarez-Cuesta E (2013) Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment. Allergy 68(7):853\u2013861","journal-title":"Allergy"},{"issue":"1","key":"3662_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaip.2013.08.011","volume":"2","author":"JT Wong","year":"2014","unstructured":"Wong JT, Ling M, Patil S, Banerji A, Long A (2014) Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization. J Allergy Clin Immunol Pract 2(1):40\u201345","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"3662_CR16","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.clinthera.2008.06.007","volume":"30","author":"H Nozawa","year":"2008","unstructured":"Nozawa H, Muto Y, Yamada Y (2008) Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer. Clin Therap 30(6):1160\u20131165","journal-title":"Clin Therap"},{"issue":"3","key":"3662_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.18176\/jiaci.0038","volume":"26","author":"H Park","year":"2016","unstructured":"Park H, Lee J, Kim S, Kim S, Park K, Lee C, Kang B, Beom S, Shin S, Jung M (2016) A new practical desensitization protocol for oxaliplatin-induced immediate hypersensitivity reactions: a necessary and useful approach. J Investig Allergol Clin Immunol 26(3):168\u2013176","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"3662_CR18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/cncr.21168","volume":"104","author":"R Confino-Cohen","year":"2005","unstructured":"Confino-Cohen R, Fishman A, Altaras M, Goldberg A (2005) Successful carboplatin desensitization in patients with proven carboplatin allergy. Cancer 104(3):640\u2013643","journal-title":"Cancer"},{"issue":"3","key":"3662_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12094-012-0909-9","volume":"15","author":"S Cortijo-Cascajares","year":"2013","unstructured":"Cortijo-Cascajares S, Nacle-L\u00f3pez I, Garc\u00eda-Escobar I, Aguilella-Vizca\u00edno MJ, Herreros-de-Tejada A, Castro HC-F, Calleja-Hern\u00e1ndez M-\u00c1 (2013) Effectiveness of oxaliplatin desensitization protocols. Clin Transl Oncol 15(3):219\u2013225","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"3662_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s10147-014-0731-1","volume":"20","author":"N Takase","year":"2015","unstructured":"Takase N, Matsumoto K, Onoe T, Kitao A, Tanioka M, Kikukawa Y, Yamaguchi S, Fujiwara K, Negoro S (2015) 4-Step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study. Int J Clin Oncol 20(3):566\u2013573","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"3662_CR21","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.clinthera.2015.03.012","volume":"37","author":"T Okayama","year":"2015","unstructured":"Okayama T, Ishikawa T, Sugatani K, Yoshida N, Kokura S, Matsuda K, Tsukamoto S, Ihara N, Kuriu Y, Nakanishi M (2015) Hypersensitivity reactions to oxaliplatin: identifying the risk factors and judging the efficacy of a desensitization protocol. Clin Therap 37(6):1259\u20131269","journal-title":"Clin Therap"},{"issue":"1","key":"3662_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ygyno.2016.09.027","volume":"144","author":"G Altwerger","year":"2017","unstructured":"Altwerger G, Gressel GM, English DP, Nelson WK, Carusillo N, Silasi D-A, Azodi M, Santin A, Schwartz PE, Ratner ES (2017) Platinum desensitization in patients with carboplatin hypersensitivity: a single-institution retrospective study. Gynecol Oncol 144(1):77\u201382","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3662_CR23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1006\/gyno.2001.6331","volume":"82","author":"JB Robinson","year":"2001","unstructured":"Robinson JB, Singh D, Bodurka-Bevers DC, Wharton JT, Gershenson DM, Wolf JK (2001) Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies. Gynecol Oncol 82(3):550\u2013558","journal-title":"Gynecol Oncol"},{"issue":"15","key":"3662_CR24","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.ejca.2005.06.021","volume":"41","author":"F Maindrault-Goebel","year":"2005","unstructured":"Maindrault-Goebel F, Andr\u00e9 T, Tournigand C, Louvet C, Perez-Staub N, Zeghib N, De Gramont A (2005) Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients. Eur J Cancer 41(15):2262\u20132267","journal-title":"Eur J Cancer"},{"issue":"5","key":"3662_CR25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00280-014-2437-5","volume":"73","author":"S-Y Lee","year":"2014","unstructured":"Lee S-Y, Kang H-R, Song W-J, Lee K-H, Han S-W, Cho SH (2014) Overcoming oxaliplatin hypersensitivity: different strategies are needed according to the severity and previous exposure. Cancer Chemother Pharmacol 73(5):1021\u20131029","journal-title":"Cancer Chemother Pharmacol"},{"key":"3662_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.12.026","author":"K-H Sohn","year":"2018","unstructured":"Sohn K-H, Kang D-Y, Kim J-Y, Lee S-Y, Lee K-H, Han S-W, Kang H-R (2018) Incidence and risk of oxaliplatin-induced hypersensitivity in patients with asymptomatic prior exposure: a prospective observational study. J Allergy Clin Immunol Pract. \n                    https:\/\/doi.org\/10.1016\/j.jaip.2017.12.026","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"3662_CR27","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/BF03024878","volume":"47","author":"M Weiss","year":"2000","unstructured":"Weiss M, Hug MI, Neff T, Fischer J (2000) Syringe size and flow rate affect drug delivery from syringe pumps. Can J Anesth 47(10):1031\u20131035","journal-title":"Can J Anesth"},{"issue":"6","key":"3662_CR28","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s001340051246","volume":"26","author":"M Weiss","year":"2000","unstructured":"Weiss M, B\u00e4nziger O, Neff T, Fanconi S (2000) Influence of infusion line compliance on drug delivery rate during acute line loop formation. Intensive Care Med 26(6):776\u2013779","journal-title":"Intensive Care Med"},{"issue":"7","key":"3662_CR29","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/all.12620","volume":"70","author":"E Alvarez-Cuesta","year":"2015","unstructured":"Alvarez-Cuesta E, Madrigal-Burgaleta R, Angel-Pereira D, Ure\u00f1a-Tavera A, Zamora-Verduga M, Lopez-Gonzalez P, Berges-Gimeno M (2015) Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization. Allergy 70(7):784\u2013794","journal-title":"Allergy"},{"issue":"5","key":"3662_CR30","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.anai.2015.07.017","volume":"115","author":"AL Wang","year":"2015","unstructured":"Wang AL, Patil SU, Long AA, Banerji A (2015) Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy. Ann Allergy Asthma Immunol 115(5):422\u2013428","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"3662_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jaci.2011.10.010","volume":"129","author":"SU Patil","year":"2012","unstructured":"Patil SU, Long AA, Ling M, Wilson MT, Hesterberg P, Wong JT, Banerji A (2012) A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions. J Allergy Clin Immunol 129(2):443\u2013447","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"3662_CR32","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jaci.2006.11.640","volume":"119","author":"V Leguy-Seguin","year":"2007","unstructured":"Leguy-Seguin V, Jolimoy G, Coudert B, Pernot C, Dalac S, Vabres P, Collet E (2007) Diagnostic and predictive value of skin testing in platinum salt hypersensitivity. J Allergy Clin Immunol 119(3):726\u2013730","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"3662_CR33","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1200\/JCO.2001.19.12.3126","volume":"19","author":"K Zanotti","year":"2001","unstructured":"Zanotti K, Rybicki L, Kennedy A, Belinson J, Webster K, Kulp B, Peterson G, Markman M (2001) Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. J Clin Oncol 19(12):3126\u20133129","journal-title":"J Clin Oncol"},{"issue":"2","key":"3662_CR34","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ygyno.2004.08.002","volume":"95","author":"C-W Lee","year":"2004","unstructured":"Lee C-W, Matulonis UA, Castells MC (2004) Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell\/IgE-mediated reactions. Gynecol Oncol 95(2):370\u2013376","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3662_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/annonc\/mdg092","volume":"14","author":"C Garufi","year":"2003","unstructured":"Garufi C, Cristaudo A, Vanni B, Bria E, Aschelter A, Santucci B, Terzoli E (2003) Skin testing and hypersensitivity reactions to oxaliplatin. Ann Oncol 14(3):497\u2013498","journal-title":"Ann Oncol"},{"issue":"3","key":"3662_CR36","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0090-8258(03)00155-0","volume":"89","author":"M Markman","year":"2003","unstructured":"Markman M, Zanotti K, Kulp B, Peterson G, Markman M (2003) Relationship between a history of systemic allergic reactions and risk of subsequent carboplatin hypersensitivity. Gynecol Oncol 89(3):514\u2013516","journal-title":"Gynecol Oncol"},{"issue":"8","key":"3662_CR37","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2217\/imt.14.71","volume":"6","author":"I Bruchim","year":"2014","unstructured":"Bruchim I, Goldberg A, Fishman A, Confino-Cohen R (2014) Carboplatin hypersensitivity: evaluation and successful desensitization protocol. Immunotherapy 6(8):905\u2013912","journal-title":"Immunotherapy"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-018-3662-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-018-3662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-018-3662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T19:16:23Z","timestamp":1565637383000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-018-3662-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,13]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["3662"],"URL":"https:\/\/doi.org\/10.1007\/s00280-018-3662-0","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,13]]},"assertion":[{"value":"23 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}